A life-changing condition often misunderstood

Hypothalamic obesity (HO) is a rare but serious condition that can develop after damage to the hypothalamus, a part of the brain that helps regulate hunger, metabolism, sleep, and hormones. This damage often occurs after treatment for brain tumors such as craniopharyngioma, especially in children.

Unlike common obesity, hypothalamic obesity is not caused by lifestyle choices. It is a complex medical condition with deep biological roots. People with HO often experience:

  • Rapid, uncontrollable weight gain — even on strict diets
  • Fatigue and low energy
  • Trouble sleeping
  • Memory and mood issues
  • Reduced quality of life

At the Raymond A. Wood Foundation (RAWF), we know that families facing this diagnosis often feel confused, dismissed, or overwhelmed. We’re here to change that.

Why does hypothalamic obesity happen?

  • Constant feelings of hunger (called hyperphagia)
  • A slowed metabolism
  • Disrupted hormone levels
  • Insulin resistance

What makes HO different?

Common ObesityHypothalamic Obesity
CauseOften lifestyle-relatedBrain injury (hypothalamus)
Hunger cuesUsually work normallyOften missing or distorted
MetabolismCan adjust to diet/exerciseSeverely disrupted
Treatment responseOften responsiveOften resistant
Emotional burdenVariableOften higher due to misunderstanding and stigma

You are not alone

  • Funding research to better understand HO and find new treatments
  • Fighting for access to therapies like GLP-1 medications and Setmelanotide
  • Connecting families through peer support and trusted information
  • Driving innovation, like our at-home sodium meter project to manage related complications

How RAWF supports families living with HO

  • Educate doctors and health systems about the realities of HO
  • Build a global patient registry to power patient-led research
  • Offer virtual education, caregiver panels, and ambassador support
  • Advocate for policy change to recognize HO as a distinct medical condition

Nutrition Management for Hypothalamic Obesity 2023 Pituitary Brain Tumor Patient Conference


Get Involved or Learn More

Image of medications with title New Frontiers in Hypothalamic Obesity: Clinical Trials Offering Hope

New Frontiers in Hypothalamic Obesity Research

Current Clinical Trials and Newly Released Data Offering Hope …
Hypothalamic Obesity Clinical Trials Update

Updates on Current and Pending Hypothalamic Obesity Clinical Trials

We are pleased to share updates on several clinical …
Building landscape

Raymond A. Wood Foundation Partners with STOP Obesity Alliance

In September 2022, Raymond A. Wood Foundation partnered with …

Dear Parents: Here’s What I Want You to Know About Managing HO

Contributed by Lynne Mathies, craniopharyngioma survivor and RAWF intern …

EN
Raymond A. Wood Foundation
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.